baber/WOPTO huggingface dataset:
Patent AU-2005202534-B2 (AU)
Title: Enriched Central Nervous System Stem Cell and Progenitor Cell Populations, and Methods for Indentifying, Isolating and Enriching for Such Populations
Inventor: BUCK DAVID W
IPC: A61P21/00
Filed: 2005-06-10
Granted: 2008-05-08
Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
Patent AU-2005318937-B2 (AU)
Title: Microbial biocementation
Inventor: AL-THAWADI SALWA MUTLAQ JUMA
IPC: C04B24/00
Filed: 2005-12-20
Granted: 2012-01-19
Abstract: A method of forming a high strength cement in a permeable starting material, the method comprising the step of combining the starting material with effective amounts of (i) a urease producing micro-organism; (ii) urea; and (iii) calcium ions and wherein the effective amount of the urease producing organism provides a urea hydrolysis rate, under standard conditions, of 0.5-50 mM urea hydrolysed.min-1.
Patent AU-2006200779-B2 (AU)
Title: Surgical hand access apparatus
Inventor: THOMAS WENCHELL
IPC: A61B17/02
Filed: 2006-02-24
Granted: 2011-07-21
Abstract: SURGICAL HAND ACCESS APPARATUS 5 A surgical access apparatus (10) adaptable to permit the sealed insertion of either the surgeon's hand and/or surgical instruments during laparoscopic and endoscopic surgical procedures includes an access member having a passageway therethrough and first and second seal members (20, 22) mounted across the passageway. The first seal includes an inner seal portion (36) and an outer seal portion (34). The inner seal portion 10 has an aperture (42) for substantial sealed reception of an object inserted therein and is arranged about a first seal axis. The outer seal portion includes at least one expansible rib (40) dimensioned to facilitate movement of the aperture to a displaced position radially displaced from the first seal axis upon insertion of the object therethrough. The second seal member also has an inner portion defining an aperture for substantial sealed reception is of the object and is arranged about a second seal axis radially displaced from the first seal axis. Preferably, the apertures of the first and second seal members are in non overlapping relation in the absence of the object positioned therein. The first seal member is adapted to move to the displaced position upon insertion of the object therethrough whereby the apertures of the first seal member and the second seal member 20 overlap. The first and second seal members are preferably adapted to form a substantial seal within the passageway of the access member in the absence of the object inserted within the aperture of the first member. The outer seal portion of the first seal member may include a plurality of expansible ribs. The expansible ribs may be arranged along respective lines of intersection with the axis of the first seal member. cm... 0k
Patent AU-2006201319-B2 (AU)
Title: Mid-foot fixation plate
Inventor: BREMER CHRIS
IPC: A61B17/58
Filed: 2006-03-29
Granted: 2011-01-27
Abstract: A fixation device for fixation and/or fusion of the bones and joints of the mid-foot includes a plate having a plurality of screw holes for attachment of the plate around the perimeter of the fusion site. Four screw holes are positioned at the corners of the plate and two screw holes are located at the opposite sides and mid-length of the plate. Preferably, four additional screw holes are defined at the interior of the plate to increase the number of points of attachment of the plate to the bones of the mid-foot or to increase the ability to stabilize multiple bone segments in the case of a difficult mid-foot fracture. The plate includes a plurality of cut-outs defined between or interior of the screw holes. The cut-outs are sized to accept additional bone fasteners to either enhance the attachment of the plate to the mid-foot bones or to provide access for a fastener to reduce a bone fragment beneath the plate. The plate is configured so that the screw holes and cut-outs are not positioned over a fusion location when the plate is attached to the mid-foot.
Patent AU-2006201567-B2 (AU)
Title: Graphical user interface for selecting pulse parameters in a phacoemulsification surgical system
Inventor: DAVID THOE
IPC: A61B19/00
Filed: 2006-04-13
Granted: 2011-11-03
Abstract: GRAPHICAL USER INTERFACE FOR SELECTING PULSE PARAMETERS IN A PHACOEMULSIFICATION SURGICAL SYSTEM A graphical user interface for use in phacoemulsification surgical systems that allows a user to select different pulse modes by touching portions of the display screen. The user interface includes first and second display elements. One display element includes a representation of the on-time of the pulses, and the other display element 10 includes a representation of the off-time. The representations show how the on-time and off-time change relative to a position of a controller, such as a foot pedal. The representation show a constant time, or that a time increases or decreases as the foot pedal is pressed. To select a pulse mode, a user can scroll through different pulse representations by touching the screen at the display elements. The selected pulse mode 15 can be continuous, pulse, burst and other modes. Ci4 o0 a (0o I I 0) 0 coR U)I
Patent AU-2006208084-B2 (AU)
Title: Quinoxaline Derivatives as Antitumor Agents
Inventor: QI LONGWU
IPC: C07D239/90
Filed: 2006-01-25
Granted: 2012-07-26
Abstract: The invention relates to methods of screening for binding partners, especially binding partners essential for the biological activity of erastin (e.g. VDACs such as VDAC3). The invention also provides reagents and methods for effective killing of cancer cells with erastin and related compounds or derivatives.
Patent AU-2006228670-B2 (AU)
Title: Phosphorylated waxy potato starch
Inventor: PILLING JENS
IPC: C12N15/82
Filed: 2006-03-30
Granted: 2012-05-17
Abstract: The invention relates to potato starches having an amylose content of less than 10% by weight, a phosphate content in the C6 position of between 35 and 100 nmol of phosphate per milligram of starch and a content of side chains having a DP of from 12 to 19 which is elevated as compared with that in potato starch from corresponding wild-type potato plants.
Patent AU-2006230735-B2 (AU)
Title: Passenger transportation system, especially an escalator or moving walk
Inventor: GUNTER STEINDL
IPC: B66B25/00
Filed: 2006-10-20
Granted: 2011-06-30
Abstract: Abstract A passenger transportation system, especially an escalator (1) or moving walk, contains a circulating band (10), a driving station (20), and a reversing station (50). The driving station (20) is arranged in the area of a first end (2) 5 of the passenger transportation system (1) and has a slave control unit (30). The reversing station (50) in the area of a second end (3) of the passenger transportation system has a master control unit (60). For the purpose of exchanging data, the master control unit (60) and the slave control unit (30) are connected together by a data bus (80). The slave control unit (30) has a 10 first printed circuit board (40) on which is mounted a first set of electronic components and which serves to transmit to the master control unit (60) data concerning the functioning of the passenger transportation system (1). The master control unit (60) has a second printed circuit board (70) on which is mounted a second set of electronic components and which serves to analyze 15 the data and control of the passenger transportation system. (Fig. 1) loo lo,80 - - ~10 2
Patent AU-2006311794-B2 (AU)
Title: Heparan sulfate glycosaminoglycan lyase and uses thereof
Inventor: MYETTE JAMES
IPC: C07H21/04
Filed: 2006-11-03
Granted: 2012-09-20
Abstract: The invention provides recombinant GAG lyase polypeptides. The invention also provides nucleic acid molecules encoding such polypeptides, recombinant expression vectors containing GAG lyase nucleic acid molecules, and host cells into which the expression vectors have been introduced. Characterization, diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
Patent AU-2006318355-B2 (AU)
Title: Materials and methods for treating viral infections with a cysteamine compound
Inventor: YI LIANG HAO
IPC: A61P31/12
Filed: 2006-11-28
Granted: 2012-01-12
Abstract: The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of a viral infection. In a preferred embodiment, a cysteamine compound is administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is administered to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus).
Patent AU-2006328943-B2 (AU)
Title: Improved method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer
Inventor: MAGNUS THORN
IPC: C12N5/0783
Filed: 2006-12-20
Granted: 2011-07-21
Abstract: The present invention discloses an improved method for expansion and activation of tumour-reactive lymphocytes, in particular CD4+ helper and/or CD8+ T-lymphocytes, which may be used for treating and/or preventing cancer. The method provides high numbers of tumour-reactive T-lymphocytes within a short time span and the possibility of directing development of tumour-reactive CD4+ helper and/or CD8+ T-lymphocytes towards specific subpopulations. The method comprises a first phase of stimulating tumour-reactive CD4+ T helper and/or CD8+ T-lymphocytes with tumour-derived antigen together with at least one substance having agonistic activity towards the IL-2 receptor to promote survival of tumour-reactive CD4+ T helper and/or CD8+ T-lymphocytes; and a second phase of activating and promoting growth of tumour-reactive CD4+ T helper and/or CD8+ T-lymphocytes, wherein the second phase is initiated when the CD25 cell surface marker (or IL-2R marker) is down-regulated on CD4+ T helper and/or CD8+ T-lymphocytes.
Patent AU-2006331619-B2 (AU)
Title: Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
Inventor: KELLY JAMES D
IPC: A61K38/00
Filed: 2006-12-21
Granted: 2012-12-20
Abstract: TSHR agonists that are substantially desialylated are described for treating metabolic syndrome and obesity and for inducing lipolysis. The TSHR polypeptide agonists are useful for treatment of hallmarks of metabolic syndrome: obesity, insulin resistance, hyperlipidemia, and liver steatosis, without producing a hyperthyroid state in treated individuals.
Patent AU-2007219544-B2 (AU)
Title: Method and apparatus for providing polymer to be used at vacuum infusion
Inventor: HANSEN TIM MOLLER
IPC: B29C48/76
Filed: 2007-03-02
Granted: 2011-04-21
Abstract: The invention relates to a method of producing a shell member of fiber composite material by means of vacuum infusion, where the fiber material is impregnated with liquid polymer, and applying a mould (18) with a mould cavity. In the mould cavity a lower distribution layer (11) is placed. A fiber insertion (1) including a plurality of fiber layers is placed above the lower distribution layer (11). A first upper distribution layer (9) and a second upper distribution layer (10) are placed at a transverse distance of each other above the fiber insertion, so that at least a part of the first distribution layer overlaps a first zone (2) of the fiber insertion (1), and at least a part of the second distribution layer overlaps a second zone (3) of the fiber insertion (1), the first zone (2) and the second zone (3) being separated by an intermediate zone (6) neither overlapping the first nor the second distribution layer (9, 10). A first inlet channel (7) is placed above the first distribution layer (9), and a second inlet channel (8) is placed on top of the second distribution layer (10). Above the intermediate zone (6) of the fiber insertion (1) a semi-permeable membrane (5) is placed, which may expand overlappingly over the first distribution layer (9) and/or the second distribution layer (10), and which is permeable to gasses and substantially impermeable to liquid polymer, said semi-permeable membrane (5) communicating with a vacuum source. Finally, in a manner known per se, a vacuum bag (19) is placed on top of the mould (18), which is evacuated of air by means of the vacuum source, and polymer is directed into the mould via the first and the second inlet channels (7, 8). The invention also relates to an apparatus for providing polymer for use with the method.
Patent AU-2007245674-B2 (AU)
Title: Copolymers as scale inhibitors
Inventor: GUZMANN MARCUS
IPC: C08F220/00
Filed: 2007-04-26
Granted: 2013-05-23
Abstract: The present invention relates to copolymers which are obtainable from the free-radical copolymerization of at least (a) a monoethylenically unsaturated carboxylic acid having from 3 to 6 carbon atoms or its anhydride with (b) a reaction mixture comprising a component of the general structural formula (I) where R
Patent AU-2007246644-B2 (AU)
Title: Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350.
Inventor: ZHANG HONG
IPC: A61K31/7072
Filed: 2007-05-04
Granted: 2010-09-30
Abstract: Co-administration of alovudine and zidovudine at ratios considerably in excess of the prior art completely or substantially abolishes the mitochondrial toxicity of alovudine in mitochondrial DNA depletion experiments. The invention thus provides pharmaceutical compositions comprising alovudine and zidovudine in a molar ratio in the range 1:100 to 1:350 and methods for the treatment or prophylaxis of multiply resistant HIV comprising the simultaneous or consequential administration of alovudine and zidovudine in the characteristic molar ratio.
Patent AU-2007305430-B2 (AU)
Title: Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
Inventor: TATA JAMES R
IPC: C07D209/18
Filed: 2007-09-27
Granted: 2011-07-21
Abstract: Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included. (I)
Patent AU-2007334317-B2 (AU)
Title: Therapeutic apparatus for relieving obstruction to the upper airway of a patient and method
Inventor: PALMER DONNA
IPC: F04D17/00
Filed: 2007-12-17
Granted: 2014-02-06
Abstract: A device and a method for creating and/or maintaining an obstruction free upper airway. The device is configured to fit under the chin of a subject adjacent to the subject's neck at an external location corresponding approximately with the subject's internal soft tissue associated with the neck's anterior triangle. The device is capable of exerting negative pressure on the surface of a subject's neck, displacing the soft tissue forward and enlarging the airway.
Patent AU-2008249165-B2 (AU)
Title: Controlling movement of a vessel traveling through water during a seismic survey operation
Inventor: WELKER KENNETH E
IPC: B63H21/21
Filed: 2008-11-21
Granted: 2013-02-14
Abstract: To perform control of movement of a marine vessel traveling through water during a seismic survey operation, input information relating to factors that affect a speed of the marine vessel is received. The speed of the marine 5 vessel is adjusted in response to the received information relating to the factors that affect the speed of the marine vessel. Ns\Melbourne\Case\Patent\79000-79999\P79612.AU\Specis\P79612AU.GHSPECI.doc 21/11/08
Patent AU-2008273852-B2 (AU)
Title: Safety plug for sealing bus bar end connections
Inventor: JAMES PARSONS
IPC: H01R4/70
Filed: 2008-05-20
Granted: 2011-07-21
Abstract: A sealed covering for exposed portions of electrical wires 55 at an "end of a protective tube 51, which houses a bus bar 52. A cover shield 60 has a first geometric shape. A plug 10 has two opposing hinged shells forming, in a closed configuration, the first geometric shape at a proximate end 16 and the second geometric shape at a distal end 20. The opposing hinged shells when closed define a cavity 14 for receiving a cable 55, and a flange 16 at the proximate end 16 for receiving said cover shield 60. A fastener 26 is provided at the proximate end 16 of the plug constructed so as to mate 62 with the cover shield 60. The shield is slipped down over the bus bar conduit tube to expose the bus bar end connector. The cable wire lug end is then connected to the bus bar. The cover shield is then slipped up to cover the bus bar end connector and attached cable wire. The end plug device is fitted around the cable and pushed into the cover shield and snapped into place by means of the male button 26 that fits into a mating female hole 62 in the cover shield 60.
Patent AU-2008283218-B2 (AU)
Title: Manufacturing method of 3D shape structure having hydrophobic inner surface
Inventor: DONG-SEOB KIM
IPC: C23C28/00
Filed: 2008-03-12
Granted: 2011-11-17
Abstract: The present invention relates to a manufacturing method of a three dimensional structure having a hydrophobic inner surface. The manufacturing method includes anodizing a three dimensional metal member and forming fine holes on an external surface of the metal member, forming a replica by coating a non-wetting polymer material on the outer surface of the metal member and forming the non-wetting polymer material to be a replication structure corresponding to the fine holes of the metal member, forming an exterior by surrounding the replication structure with an exterior forming material, and etching the metal member and eliminating the metal member from the replication structure and the exterior forming material.
Patent AU-2008305400-B2 (AU)
Title: Surgical implant with an anti-backout feature
Inventor: LINDERMANN GARY S
IPC: A61B17/80
Filed: 2008-09-05
Granted: 2013-06-06
Abstract: The present application is directed to an implant maintained within the patient by a fastener. The implant includes an aperture sized to receive the fastener. A locking member extends across the aperture in a first position. The locking member is constructed of a resilient material that is movable to a second position during insertion of the fastener. Once the fastener is inserted within the aperture below a level of the locking member, the locking member rebounds towards the first position and extends over the fastener. The locking member prevents the fastener from backing out of the implant.
Patent AU-2008321253-B2 (AU)
Title: Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
Inventor: BOURDON JEAN-CHRISTOPHE
IPC: A61P35/00
Filed: 2008-10-21
Granted: 2014-01-16
Abstract: The present invention provides methods and compositions for modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. The methods and compositions of the invention find use in inhibiting cancer cell growth or in generating populations of cells for tissue regeneration through the modulation of cell senescence and proliferation.
Patent AU-2008337695-B2 (AU)
Title: Method for the treatment of water using chlorine dioxide
Inventor: DUVE HANS
IPC: C02F1/76
Filed: 2008-11-28
Granted: 2013-04-18
Abstract: The invention relates to a method for the treatment of water using chlorine dioxide (C102), wherein the reaction chamber, in which the C102 is created, is completely surrounded by the water to be treated. The C102 created in the reaction chamber is directly added to the water to be treated from the reaction chamber. The conductivity value in the solution exiting the reaction chamber can be measured. Preferably the C102 is created from sodium chlorite using hydrochloric acid.
Patent AU-2008339047-B2 (AU)
Title: Weapon robot with situational awareness
Inventor: DEGUIRE DANIEL R
IPC: G06F19/00
Filed: 2008-07-17
Granted: 2011-09-22
Abstract: A mobile, remotely controlled robot includes a turret subsystem, a robot controller subsystem configured to control the robot, control the turret, and fire the weapon, a robot navigation subsystem configured to determine the position of the robot, a turret orientation determination subsystem, and a robot communications subsystem for receiving commands and for transmitting robot position data and turret orientation data. An operator control unit communications subsystem transmits commands to the robot and receives robot position data and turret orientation data from the robot. An operator control unit navigation subsystem is configured to determine the position of the operator control unit. An operator control unit controller subsystem is responsive to the robot position data, the turret onentation data, and the operator control unit position and is configured to determine if the weapon is aimed at the operator control unit within a predetermined fan angle.
Patent AU-2008351158-B2 (AU)
Title: Lock ring for an osteosynthesis device and osteosynthesis device including such ring
Inventor: WORCEL ALEXANDRE
IPC: A61B17/60
Filed: 2008-12-12
Granted: 2014-01-23
Abstract: The invention relates to a blocking ring (20) for a threaded holding pin (18) to be screwed into a portion of a bone (14), said ring including a first portion (22) having an axial bore (24) for receiving said holding pin, the periphery of said first portion being threaded so as to interact with a holding plate (12), wherein said ring is characterised in that the same further comprises, as an extension to said first portion, a second deformable portion (28, 44) having a thickness lower than the first portion and having a similar axial bore (30, 46), and in that the shearing of the pin (18) and the ring at the join between the first portion (22) and the second portion (28) deforms the remaining portion (34) of the second portion (28) of the blocking ring (22) towards the pin (18) in such a way as to block the pin (18) in relation to the blocking ring (22) by crimping.
Patent AU-2008360070-B2 (AU)
Title: Tablet manufacturing method
Inventor: AL ALAWI FADIL
IPC: A61K31/365
Filed: 2008-07-29
Granted: 2015-04-30
Abstract: A method of manufacturing a tablet formulated for administration to an animal containing at least one macrocyclic lactone compound and at least one additional compound with anthelmintic activity by the steps of: (a) dissolving the macrocyclic lactone compound or compounds in at least one organic solvent; (b) combining the mixture of step (a) with at least one organic co-solvent; (c) combining the mixture of step (b) with: i. at least one additional compound with anthelmintic activity; ii. at least one binder compound; iii. at least one filler / bulking agent compound; and, (d) drying the mixture of step (c).
Patent AU-2008361655-B2 (AU)
Title: Identification wristband
Inventor: KERLIN JEFFREY
IPC: B42D15/00
Filed: 2008-09-16
Granted: 2016-01-14
Abstract: An identification wristband includes a liner layer permanently affixed to one end thereof, which covers an adhesive whereby the wristband may be secured to a person or object in a looped fashion securing the ends of the wristband together. The liner releasably covers a portion of the adhesive and is permanently attached to an adjacent portion of the adhesive. In this way, the liner is not separable from the wristband. The liner includes a first portion which is not adhered to the wristband to allow for ease of separation. The liner layer also includes a second portion that is not adhered to the wristband to ensure against accidentally exposed adhesive.